219 related articles for article (PubMed ID: 38322590)
1. DARS-AS1: A Vital Oncogenic LncRNA Regulator with Potential for Cancer Prognosis and Therapy.
Shu J; Xia K; Luo H; Wang Y
Int J Med Sci; 2024; 21(3):571-582. PubMed ID: 38322590
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Long Noncoding RNA DARS-AS1 in Childhood Acute Myeloid Leukemia by Binding to microRNA-425.
Dou B; Jiang Z; Chen X; Wang C; Wu J; An J; Sheng G
Technol Cancer Res Treat; 2020; 19():1533033820965580. PubMed ID: 33073700
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
4. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
Jiao M; Guo H; Chen Y; Li L; Zhang L
Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA DARS-AS1 promotes tumor progression by directly suppressing PACT-mediated cellular stress.
Yang L; Lin K; Zhu L; Wang H; Teng S; Huang L; Zhou S; Zhang G; Lu ZJ; Wang D
Commun Biol; 2022 Aug; 5(1):822. PubMed ID: 35970927
[TBL] [Abstract][Full Text] [Related]
7. LncRNA DARS-AS1 in human cancers: A comprehensive review of its potency as a biomarker and therapeutic target.
Dang Q
Gene; 2024 May; 923():148566. PubMed ID: 38762015
[TBL] [Abstract][Full Text] [Related]
8. The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility.
Su Y; Li C; Fang Y; Gu X; Zheng Q; Lu J; Li L
Clin Transl Oncol; 2023 Feb; 25(2):293-305. PubMed ID: 36131071
[TBL] [Abstract][Full Text] [Related]
9. Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 axis.
Liu Y; Liang L; Ji L; Zhang F; Chen D; Duan S; Shen H; Liang Y; Chen Y
Aging (Albany NY); 2021 Oct; 13(19):23376-23392. PubMed ID: 34644678
[TBL] [Abstract][Full Text] [Related]
10. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA DARS-AS1 regulates TP53 ubiquitination and affects ovarian cancer progression by modulation miR-194-5p/RBX1 axis.
Zhou M; Cheng H; Fu Y; Zhang J
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22865. PubMed ID: 34328246
[TBL] [Abstract][Full Text] [Related]
12. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
14. DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m
Shen W; Zhu M; Wang Q; Zhou X; Wang J; Wang T; Zhang J
RNA Biol; 2022 Jan; 19(1):751-763. PubMed ID: 35638109
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway.
Kong X; Wang JS; Yang H
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-11. PubMed ID: 33634536
[TBL] [Abstract][Full Text] [Related]
16. DARS-AS1 Knockdown Inhibits the Growth of Cervical Cancer Cells via Downregulating HMGB1 via Sponging miR-188-5p.
Zhu J; Han S
Technol Cancer Res Treat; 2020; 19():1533033820971669. PubMed ID: 33176595
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract][Full Text] [Related]
18. Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis.
Liu X; Zhang G; Yu T; He J; Liu J; Chai X; Zhao G; Yin D; Zhang C
Cancer Lett; 2022 Sep; 543():215781. PubMed ID: 35688263
[TBL] [Abstract][Full Text] [Related]
19. lncRNA DARS-AS1 Promoted Osteosarcoma Progression through Regulating miR-532-3p/CCR7.
Xue Y; Liu H; Nie G; Ren X
Dis Markers; 2022; 2022():4660217. PubMed ID: 35422889
[TBL] [Abstract][Full Text] [Related]
20. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]